Apricus Biosciences to Present at 2013 BIO International Convention
SAN DIEGO, April 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc.
("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced
today that Edward Cox, Vice President Corporate Development & Investor
Relations, will present at the 2013 BIO International Convention on Wednesday,
April 24, 2013 at 4:15 p.m. local time at McCormick Place, Chicago Bears Room,
in Chicago, Illinois. Mr. Cox will present a company overview.
About Apricus Biosciences, Inc.
Apricus Biosciences, Inc. (Nasdaq:APRI) is a pharmaceutical company that
develops and markets innovative treatments that help large patient populations
across numerous, large-market therapeutic classes including male and female
sexual health. The Company has one approved product, Vitaros^®, for the
treatment of erectile dysfunction, which will be marketed in Canada by Abbott
Laboratories, and Femprox^®, a product candidate, for the treatment of female
sexual arousal disorder, which successfully completed one approximately
400-patient Phase III study in China.
For further information on Apricus Bio, visit http://www.apricusbio.com. You
can also receive information at http://twitter.com/apricusbio.
CONTACT: Apricus Bio Investor Relations:
David Pitts or Lourdes Catala
Press spacebar to pause and continue. Press esc to stop.